Short-Term Relief for COVID-19 Administrative Requirements Guidance

As of April 3, 2020

Grantees must contact their IDPH Grant Manager with questions, and to request any of the below extensions.  All Flexibilities must be approved by funding source.

Thank you for your patience as we work to maintain service delivery during this time.

The federal Office of Management and Budget is allowing flexibilities in administrative requirements for services necessary to for emergency response or loss of operations, as specified. See chart below.

Donation of Convalescent Plasma

Convalescent Plasma for the Treatment of COVID-19 and Donation of Convalescent Plasma
Use of convalescent plasma to treat COVID-19 patients

People who have recovered from COVID-19 have antibodies – proteins the body uses to fight off infections – to the disease in their blood. Doctors call this convalescent plasma. COVID-19 convalescent plasma has not yet been approved for use by the Food and Drug Administration (FDA) and is regulated as an investigational product.  A study by Mayo Clinic researchers of 20,000 hospitalized patients transfused with investigational convalescent plasma published in June 2020 concluded there was “robust evidence” it was safe and supported earlier administration of plasma within the clinical course of COVID-19 was “more likely to reduce mortality.” The following pathways are available for the use of COVID-19 convalescent plasma:

Health Care Providers & Facilities

Reporting COVID-19

  • All providers and testing sites must report to Public Health all individuals tested for COVID-19, in accordance with the Illinois Control of Communicable Diseases Code (77 Ill. Adm. Code 690.200(a)(5)).
  • Mandated reporters, such as health care providers, hospitals and laboratories, by law must report probable or confirmed cases of COVID-19 electronically through Illinois’ National Electronic Disease Surveillance System (I-NEDSS) within 24 hours. If they do not have access to I-NEDSS, they can report by mail, telephone or fax to the local health department (for a list see http://www.idph.state.il.us/LHDMap/HealthRegions.aspx) or, if no local health department is available, to the Illinois Department of Public Health Division of Infectious Diseases at 217-785-7165, TTY (hearing impaired use only) 800-547-0466.

LHD Guidance Disclosure of COVID-19 Persons to Law Enforcement

This guidance is intended to clarify guidance issued April 1, 2020 that may have caused confusion regarding the disclosure of COVID-19-positive persons to law enforcement and address questions that have been raised.

Guidance from the Illinois Attorney General

The Office of the Illinois Attorney General (OAG) was asked to address whether the Health Insurance Portability and Accountability Act (HIPAA) allows local health departments to provide information to law enforcement regarding individuals with positive tests for COVID-19. In response, on March 27, 2020, during a presentation to state’s attorneys, the OAG advised such disclosure is permissible because of a HIPAA exception. Specifically, the OAG  affirmed the exception applies because “disclosure to first responders will enable them to use personal protective equipment (PPE) to reduce the risk of COVID-19 transmission.”

Pages

Subscribe to RSS - Local Health Departments